CVE Intelligence
Skip to main content
HIGH

CVE-2021-43355

CVE-2021-43355 — Fresenius Kabi Agilia Connect Infusion System use of client side authentication

Fresenius Kabi Vigilant Software Suite (Mastermed Dashboard) version 2.0.1.3 allows user input to be validated on the client side without authentication by the server. The server should not rely on the correctness of the data because users might not support or block JavaScript or intentionally bypass the client-side checks. An attacker with knowledge of the service user could circumvent the client-side control and login with service privileges.

Published Updated Sources: cvelistV5, icscert

Triage

Is it exploited, how likely is exploitation, what does it touch, and how severe do the scoring sources call it.

Exploitation

Unreported

no source claims exploitation

EPSS

1%

chance of exploitation in 30 days

Affects

fresenius kabi

vigilant_software_suite_mastermed_dashboard

CVSS base

7.3

HIGH

CISA SSVC assessment

Three decision points CISA publishes for the CVEs it assesses · SSVC 2.0.3. A stakeholder decision, not a severity score.

CISA

Exploitation

None

none · proof-of-concept · active

Automatable

Yes

can an attacker script all four kill-chain steps

Technical impact

Partial

partial · total control of the vulnerable component

Affected scope

The catalog records vendors and products as separate lists, not pairs, so which product belongs to which vendor is not something this page can say.

Vendors (1)

Products (1)

vigilant software suite mastermed dashboard

Every base score collected

Sources score independently and disagree; each row says who scored it and under which version.

ScoreVersionSeverityExpl.ImpactSource
7.3CVSS 3.1HIGH——cvelistV5

Weakness & attack patterns

  • CWE-603

References

1 on the record

Elsewhere on this site

Not in any source we poll

Listed rather than left blank: an empty field and an unmeasured one look identical on screen, and only one is a reason to look elsewhere.

  • No confirmed IOCs, IP addresses, domains, file hashes, or malware artifacts supplied.
  • No organization-specific asset inventory, compensating-control status, or patch deployment evidence supplied.
  • No exploit packet captures, log samples, or incident case IDs supplied.